Skip to content
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:

Johnson & Johnson has inaugurated the Innovation Hub at Campus Basel


Johnson & Johnson moved into the new Basel Campus – one of 9 J&J sites in Switzerland – only a few months ago. Now the Johnson & Johnson Innovation Hub Switzerland was inaugurated at this campus.

Share expand

Supporting innovation in Switzerland is a matter close to Johnson & Johnson's heart. That is why the Johnson & Johnson (J&J) Innovation Hub Switzerland was recently opened at the Basel/Allschwil site. Situated within our J&J offices in Basel, the Hub will further support our Innovation team in fostering connections with external collaborators from the abundant innovation ecosystem in Switzerland.

Johnson & Johnson Innovation’s mission is to find the best early-stage innovations that could transform health outcomes for patients, wherever they originate. The team prides itself on being able to spot and nurture the right opportunities at the right times, and over the last 10 years (2014-2023) have invested over $1.7 Billion in collaborations* in the EMEA region. Their approach is to work hand in hand with researchers and company founders with biotech and medtech innovations at an early stage, helping to accelerate their ideas.

Share expand

They meet innovators where they are, supporting them every step of the way and providing a unique perspective through expertise across both Innovative Medicine and Medtech. The team also understand the uniqueness of each partnership and can personalize support to include: collaboration and deal making; incubation and acceleration through J&J Innovation – JLABS; and equity investment through J&J Innovation JJDC, Inc. Alongside this, collaborators can access expertise from across J&J and our network.

In Basel, J&J Innovation is a part of the BaseLaunch Healthcare Accelerator, which provides support to Swiss start-ups and prepares them for partnerships with pharmaceutical and venture capital companies. Last year, JLABS @ EMEA also welcomed two Swiss start-ups, one working on cell therapies against cancer and the other a virtual reality solution for planning surgical interventions."

* through our London Innovation Centre and Johnson & Johnson Innovation – JJDC Inc.

We Value Your Privacy

We use cookies to allow our site to work properly, to provide social media features and to analyse our traffic. Data may be shared with our partners involved in the delivery and/or personalization of ads on elsewhere online as explained in Cookie settings.

Please click “Accept” if you agree to our use of cookies, "Cookie Settings" to manage your preferences, or “Reject” if you only agree to necessary cookies.
Close cookie banner icon
Back to top